tiletamine hydrochloride has been researched along with BH4 Deficiency in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heiner-Fokkema, MR; Lubout, CMA; Rodenburg, IL; van der Klauw, MM; van Ginkel, WG; van Spronsen, FJ; van Vliet, K; Wolffenbuttel, BHR | 1 |
Arning, E; Bottiglieri, T; Gibson, KM; Grompe, M; Harding, CO; Winn, SR | 1 |
2 other study(ies) available for tiletamine hydrochloride and BH4 Deficiency
Article | Year |
---|---|
Biomarkers of Micronutrients in Regular Follow-Up for Tyrosinemia Type 1 and Phenylketonuria Patients.
Topics: Adolescent; Adult; Aged; Amino Acids; Biomarkers; Biopterins; Child; Child, Preschool; Cyclohexanones; Diet, Protein-Restricted; Dietary Supplements; Enzyme Inhibitors; Female; Humans; Infant; Male; Micronutrients; Middle Aged; Nitrobenzoates; Nutritional Status; Phenylketonurias; Retrospective Studies; Risk Assessment; Risk Factors; Tyrosinemias; Vitamin B 12 Deficiency; Vitamin D Deficiency; Young Adult | 2019 |
Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU).
Topics: Amino Acids; Animals; Brain Chemistry; Cyclohexanones; Dopamine; Enzyme Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurotransmitter Agents; Nitrobenzoates; Phenylketonurias; Tyrosine | 2014 |